This is an observational study called MCW Master Predict, which aims to understand how different cancer therapies work for patients at the Medical College of Wisconsin Cancer Center. The study is not testing a new drug or treatment. Instead, it's collecting information from patients who are already receiving cancer care. Researchers will look at how many people receive "precision therapies" (treatments tailored to a person's specific cancer) and how many do not, and they will collect biological samples (like blood or tissue) from these groups. This helps researchers learn more about cancer and how to personalize treatments. You can join if you are 18 or older and have received or are currently receiving cancer care at MCW/FH. The study is currently not recruiting, as its status is unclear.

Study design

This is an observational study with a planned enrollment of 10,000 participants. It is a single-site study at MCW/FH.

What's involved

You would allow researchers to use your health information, both past and future. You may also be asked to provide biological samples like blood, stool, or urine for research.

Compensation

Not stated in the trial record.

Follow-up

Information will be collected for one year to see who receives precision therapies and who does not, and if they provide biospecimens.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.